Richfield, MN, United States

Adler Graduate School

www.alfredadler.edu
Richfield, MN, United States

Adler Graduate School is a non-profit educational institution located in Richfield, Minnesota, USA, that offers a Master of Arts Degree in Adlerian Counseling and Psychotherapy. The six areas of emphasis are Marriage and Family Therapy, Licensed Professional Counseling/Licensed Professional Clinical Counseling, School Counseling, Career Development, Co-Occurring Disorders and Art Therapy. An online MA in Adlerian Studies was added in fall 2010. The school offers certificate programs in Professional Life Coaching, and Parent Coaching, a Post-Master's Degree Diploma in Adlerian Psychotherapy and a Post-Master's Licensure Program.The coursework offered at the Adler Graduate School is intended to support pursuit of licensure as an LMFT , LPC , LPCC and Professional School Counselor in the State of Minnesota. Students seeking licensure in Marriage and Family Therapy, Professional Counseling, Professional Clinical Counseling and Professional School Counseling are encouraged to consult program advisors regarding course requirements.The Adler Graduate School and the Chicago-based Adler School of Professional Psychology are independent of one another and institutionally unaffiliated. Wikipedia.

SEARCH FILTERS
Time filter
Source Type

News Article | May 23, 2017
Site: www.prweb.com

BestColleges.com, a leading provider of higher education information and resources, today announced a series of new rankings focused on degree opportunities in the Social Services. “The most rewarding work is having the opportunity to help others. We celebrate Mental Health Awareness Month by releasing a new series of rankings that feature online education programs in the Social Services. Our goal is to inspire, grow, and expand the all-important workforce that specializes in mental health and social services,” said Stephanie Snider, General Manager, BestColleges.com The Rankings with the top ten schools from each list of twenty-five: Bachelor’s in Sociology 1. University of Central Florida 2. Arizona State University - Tempe 3. Central Washington University 4. Brandman University 5. University of Colorado Denver 6. University of Nebraska at Omaha 7. Fort Hays State University 8. Oregon State University 9. North Dakota State University 10. South Dakota State University Bachelor’s in Psychology 1. University of Central Florida 2. University of Illinois at Urbana-Champaign 3. Liberty University 4. University of North Dakota 5. University of Florida - Online 6. Trine University - Regional/Non-Traditional Campuses 7. LeTourneau University 8. University of Massachusetts - Lowell 9. Florida International University 10. Old Dominion University Bachelor’s in Counseling 1. John Wesley University 2. Johnson University 3. Indiana Wesleyan University - Marion 4. University of Cincinnati 5. University of South Dakota 6. Crown College 7. Northwestern State University of Louisiana 8. Oral Roberts University 9. Grace College and Theological Seminary 10. University of Central Arkansas Master’s in Psychology 1. Harvard University 2. University of Georgia 3. Touro University Worldwide 4. Nova Southeastern University 5. Adler Graduate School 6. Adler University 7. William James College 8. The University of Tennessee - Knoxville 9. The Chicago School of Professional Psychology at Los Angeles 10. Carlos Albizu University - Miami Master’s in Social Work 1. Columbia University in the City of New York 2. University of Southern California 3. Case Western Reserve University 4. Boston University 5. University of Central Florida 6. Fordham University 7. University of Denver 8. University at Buffalo 9. Ohio State University 10. California State University - Long Beach Master’s in School Counseling 1. Lehigh University 2. New York University 3. Wake Forest University 4. Liberty University 5. University of Missouri - Columbia 6. University of North Dakota 7. University of West Alabama 8. Seton Hall University 9. Concordia University - Wisconsin 10. Missouri Baptist University Full rankings can be found on each subject page by following the hyperlink in the titles. The 2017 rankings reflect the most recent data compiled from IPEDS and the College Navigator, both of which are hosted by the National Center for Education Statistics. The goal is to objectively assess relative quality based on academic outcomes, affordability, and the breadth and depth of online learning opportunities. Each school must meet the minimum criteria of being an accredited public or private, not-for-profit institution, and submit an annual report the the National Center for Education Statistics. More information on methodology can be found here: http://www.bestcolleges.com/subject-ranking-methodology/ About BestColleges.com: BestColleges.com helps prospective students find the school that best meets their needs through proprietary research, user-friendly guides, and hundreds of unique college rankings. They also provide a wide array of college planning, financial aid, and career resources to help all students get the most from their education and prepare them for the world after college.


Counsell A.,York University | Furtado M.,START Clinic for Mood and Anxiety Disorders | Iorio C.,START Clinic for Mood and Anxiety Disorders | Iorio C.,Lakehead University | And 8 more authors.
Psychiatry Research | Year: 2017

Research suggests that Intolerance of Uncertainty (IU) is related to the severity of suffering in Generalized Anxiety Disorder (GAD). However, its role in Social Anxiety Disorder (SAD) has not been extensively studied. This study examines IU in a clinical sample of 248 individuals referred to a tertiary care clinic. Few individuals had a diagnosis of pure SAD or pure GAD, but we examined differences of IU scores by diagnostic category. We further examined the relationships between IU scores, social anxiety scores, and worry through a structural equation model. We found that diagnostic category (SAD versus GAD) accounted for little variability in IU scores, but IU scores were strongly related to symptoms of both GAD and SAD. Results highlight that IU is related to both social anxiety and worry; however aspects of IU associated with being unable to act or avoiding uncertainty are more strongly associated with SAD symptoms, whereas aspects of IU more associated with general stress and perceiving uncertainty as unfair are more strongly associated with GAD symptoms. Our results suggest that IU is an important concept for both social anxiety and generalized anxiety, however the relationship between IU and symptoms of these disorders manifests differently. © 2017 Elsevier Ireland Ltd


PubMed | University of California at San Diego, Adler Graduate School and Center for Addiction and Mental Health
Type: | Journal: Early intervention in psychiatry | Year: 2016

To conduct a preliminary feasibility examination of cognitive-behavioural social skills training (CBSST) in a first-episode psychosis population.Twenty two first-episode psychosis clients participated in an 18-week CBSST group adapted for a younger population.Adaptive functioning significantly improved following group participation and was maintained at 3-month follow-up.The CBSST group was feasible and well accepted in the first episode programme. These preliminary findings warrant further testing in a larger trial to determine efficacy.


Katzman M.A.,START Clinic for Mood and Anxiety Disorders | Katzman M.A.,Lakehead University | Katzman M.A.,University of Toronto | Katzman M.A.,Adler Graduate School | And 4 more authors.
Psychiatry Research | Year: 2014

By 2020, depression is projected to be among the most important contributors to the global burden of disease. A plethora of data confirms that despite the availability of effective therapies, major depressive disorder continues to exact an enormous toll; this, in part, is due to difficulties reaching complete remission, as well as the specific associated costs of both the disorder's morbidity and mortality. The negative effects of depression include those on patients' occupational functioning, including absenteeism, presenteeism, and reduced opportunities for educational and work success. The use of management algorithms has been shown to improve treatment outcomes in major depressive disorder and may be less costly than "usual care" practices. Nevertheless, many patients with depression remain untreated. As well, even those who are treated often continue to experience suboptimal quality of life. As such, the treatment algorithms in this article may improve outcomes for patients suffering with depression. This paper introduces some of the principal reasons underlying these treatment gaps and examines measures or recommendations that might be changed or strengthened in future practice guidelines to bridge them. © 2014 Elsevier Ireland Ltd.


Katzman M.A.,START Clinic for Mood and Anxiety Disorders | Katzman M.A.,Lakehead University | Katzman M.A.,University of Toronto | Katzman M.A.,Adler Graduate School | And 3 more authors.
CNS Drugs | Year: 2014

Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioural disorder with onset during childhood. It affects a child's development, both at home and at school, and impacts on social, emotional and cognitive functioning, in both the home and the school environment. Untreated ADHD is very often associated with poor academic achievement, low occupational status, increased risk of substance abuse and delinquency. Current practice guidelines recommend a multimodal approach in the treatment of ADHD, which includes educational, behavioural and mental health interventions, and pharmacological management. Stimulant medications, including methylphenidate (MPH) and amphetamine products, are recommended as first-line pharmacotherapy in the treatment of ADHD. The choice of stimulant is influenced by several factors; the most influential factor is the duration of action. Long-acting medication provides benefits long after school and work. It also increases the likelihood of once-daily dosing, thereby eliminating the need for mid-day dosing, making the treatment more private, avoiding stigma and improving adherence to medication. MPH is the most widely used psychotropic medication in child psychiatry. It was first developed for use in children as an oral, immediate-release formulation and more recently as various extended-release formulations. These latter formulations include the 12 h preparation Concerta® (osmotic-release oral system [OROS] MPH), which utilizes an osmotic pump system, designed to overcome the difficulties of multiple daily dosing. Since it received approval from the US Food and Drug Administration in August 2000, OROS MPH has been quickly and widely accepted as one of the preferred treatments for ADHD because of its once-daily dosing. This paper reviews the data in support of long-acting OROS MPH in children, adolescents and adults, both in ADHD and in association with its comorbidities. © 2014 Springer International Publishing Switzerland.


Sternat T.,START Clinic for Mood and Anxiety Disorders | Sternat T.,Adler Graduate School | Katzman M.A.,START Clinic for Mood and Anxiety Disorders | Katzman M.A.,Adler Graduate School | Katzman M.A.,Lakehead University
Neuropsychiatric Disease and Treatment | Year: 2016

Anhedonia, defined as the state of reduced ability to experience feelings of pleasure, is one of the hallmarks of depression. Hedonic tone is the trait underlying one’s characteristic ability to feel pleasure. Low hedonic tone represents a reduced capacity to experience pleasure, thus increasing the likelihood of experiencing anhedonia. Low hedonic tone has been associated with several psychopathologies, including major depressive disorder (MDD), substance use, and attention-deficit hyperactivity disorder (ADHD). The main neural pathway that modulates emotional affect comprises the limbic-cortical-striatal-pallidal-thalamic circuits. The activity of various components of the limbic-cortical-striatal-pallidal-thalamic pathway is correlated with hedonic tone in healthy individuals and is altered in MDD. Dysfunction of these circuits has also been implicated in the relative ineffectiveness of selective serotonin reuptake inhibitors used to treat anxiety and depression in patients with low hedonic tone. Mood disorders such as MDD, ADHD, and substance abuse share low hedonic tone as well as altered activation of brain regions involved in reward processing and monoamine signaling as their features. Given the common features of these disorders, it is not surprising that they have high levels of comorbidities. The purpose of this article is to review the neurobiology of hedonic tone as it pertains to depression, ADHD, and the potential for substance abuse. We propose that, since low hedonic tone is a shared feature of MDD, ADHD, and substance abuse, evaluation of hedonic tone may become a diagnostic feature used to predict subtypes of MDD, such as treatment-resistant depression, as well as comorbidities of these disorders. © 2016 Sternat and Katzman.


Furtado M.,START Clinic for Mood and Anxiety Disorders | Katzman M.A.,START Clinic for Mood and Anxiety Disorders | Katzman M.A.,University of Toronto | Katzman M.A.,Lakehead University | Katzman M.A.,Adler Graduate School
Psychiatry Research | Year: 2015

Recent findings have established a connection between inflammation and major depression and specifically the role of the hypothalamic-pituitary-adrenal (HPA) axis in depression. This article reviews clinical and experimental studies examining the role of the HPA axis, HPA hyperactivity (resulting in increased cortisol levels), as well as the proinflammatory cytokines tumor necrosis factor, C-reactive protein, and the interleukins, in depressed patients. Similarly this paper will review data supporting increased cytokine levels in depression and specifically differential effects in treatment-resistant patients, as well as potentially distinguishing in particular depression subtypes. Understanding the role of the immune system and inflammation in patients with major depression is essential in order to develop efficacious treatments potentially targeting inflammation in relation to the depression in order to reduce patient symptomatology and comorbidities. © 2015 .


Furtado M.,START Clinic for Mood and Anxiety Disorders | Katzman M.A.,START Clinic for Mood and Anxiety Disorders | Katzman M.A.,University of Toronto | Katzman M.A.,Lakehead University | Katzman M.A.,Adler Graduate School
Psychiatry Research | Year: 2015

As prevalence of anxiety, posttraumatic stress, and obsessive compulsive disorders continue to rise worldwide, increasing focus has been placed on immune mediated theories in understanding the underlying mechanisms of these disorders. Associations between the dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and these disorders have been recognized in the scientific literature, specifically in regard to cortisol levels, as well as changes in pro- and anti-inflammatory cytokines. The present commentary will systematically assess the scientific literature within the past decade in regard to the psychoneuroimmunology of anxiety, posttraumatic stress, and obsessive compulsive disorders. Understanding the mechanisms of these disorders is essential in order to determine efficacious and targeted treatment strategies, which may lead to substantial improvements in overall functioning, as well as significant decreases in societal and economic burden. © 2015 Elsevier Ireland Ltd.


Epstein I.,START Clinic for Mood and Anxiety Disorders | Epstein I.,University of Toronto | Szpindel I.,START Clinic for Mood and Anxiety Disorders | Katzman M.A.,START Clinic for Mood and Anxiety Disorders | And 3 more authors.
Psychiatry Research | Year: 2014

Major depressive disorder (MDD) is a highly prevalent chronic psychiatric illness associated with significant morbidity, mortality, loss of productivity, and diminished quality of life. Typically, only a minority of patients responds to treatment and meet criteria for remission as residual symptoms may persist, the result of an inadequate course of treatment and/or the presence of persistent side effects. The foremost goal of treatment should be to restore patients to full functioning and eliminate or relieve all MDD symptoms, while being virtually free of troublesome side effects. The current available pharmacological options to manage persistent depressive symptoms include augmentation or adjunctive combination strategies, both of which target selected psychobiological systems and specific mood and somatic symptoms experienced by the patient. As well, non-pharmacological interventions including psychotherapies may be used in either first-line or adjunctive approaches. However, the evidence to date with respect to available adjunct therapies is limited by few studies and those published have utilized only a small number of subjects and lack enough data to allow for a consensus of expert opinion. This underlines the need for further longer term, large population-based studies and those that include comorbid populations, all of which are seen in real world community psychiatry. © 2014 Elsevier Ireland Ltd.

Loading Adler Graduate School collaborators
Loading Adler Graduate School collaborators